Danaher Corporation DHR

Revenue Intelligence Report • 68 quarters of SEC filing data • Updated 2026-03-15

Danaher Corporation has a forecasted full-year revenue of $27B, a +10.2% year-over-year change, based on 68 quarters of SEC filing data. Key revenue drivers include R&D ($6.86 per $1) and SG&A ($2.81 per $1). The ARDL model has 7.4% MAPE.

Investment Thesis

The econometric model achieves strong accuracy (7.4% MAPE), suggesting Danaher Corporation's revenue trajectory is well-characterized by its spending patterns. Every $1 of R&D investment is associated with $6.86 of revenue, indicating efficient capital deployment in innovation. Each $1 of SG&A spending generates $2.81 in revenue, reflecting strong commercial efficiency.

Next FY Revenue
$27.1B
+10.2% YoY
R&D Multiplier
$6.86 per $1
SG&A Multiplier
$2.81 per $1
Model Accuracy
7.4% MAPE
Holdout validation: The model predicted $6.7B vs the actual $6.8B — an error of 1.8%.

Revenue Forecast

DHR Revenue Forecast

Quarterly Detail

QuarterModel ForecastActual95% RangeYoY GrowthStatus
Q4 2025 $6.7B $6.8B $5.7B – $7.7B +2.7% ✓ In range
Q1 2026 $6.8B $5.4B – $8.2B +18.5%
Q2 2026 $6.6B $4.8B – $8.3B +10.6%
Q3 2026 $6.8B $4.8B – $8.9B +13.0%
Q4 2026 $6.9B $4.6B – $9.1B +0.3%

Seasonal Factors

Multiplicative seasonal adjustment: These factors capture Danaher Corporation's systematic quarterly revenue patterns relative to the trend model. A factor of 1.05 means that quarter typically runs 5% above the underlying trend; 0.95 means 5% below. Factors are computed as the median of (actual / fitted) across all available quarters.
Fiscal QuarterSeasonal Factorvs TrendInterpretationObs.
FQ1 (Sep–Nov) 1.0111 +1.1% In line with trend 16
FQ2 (Dec–Feb) 1.0502 +5.0% +5.0% above trend 16
FQ3 (Mar–May) 0.9467 -5.3% -5.3% below trend 16
FQ4 (Jun–Aug) 1.0084 +0.8% In line with trend 16

How Spending Drives Revenue

DHR Spending Timing
Reading this chart: Each line shows the cumulative revenue generated per $1 spent over subsequent quarters. The effect builds over 4-5 quarters as investments mature.

Want this analysis for your portfolio?

I build custom revenue intelligence reports for investors and companies using SEC filing data, econometric modeling, and AI-powered insights.

Get in Touch

Data sourced from SEC EDGAR XBRL filings. Model: ARDL (linear) with 68 quarters. This analysis is for informational purposes only and does not constitute investment advice.

More in Healthcare

ABBV ALGN VRTX BAX ISRG BIIB A CI